India’s Global Capability Centres (GCCs) in the life sciences sector are rapidly evolving from traditional support roles to strategic hubs for innovation and specialized expertise. With over 36 pharma-focused GCCs predominantly located in cities like Bengaluru, Hyderabad, Mumbai, and Delhi-NCR, these centres are integral to global pharmaceutical operations, contributing to areas such as drug discovery, clinical development, and digital health. This shift reflects India’s commitment to not only cost-effective manufacturing but also to fostering an environment rich in skilled talent, particularly in technology and data science. The growing collaboration between these GCCs and multinational companies signals a reimagining of India’s role in the global life sciences value chain, positioning the country as a critical player in shaping future pharmaceutical innovations. Despite challenges in talent acquisition and regulatory compliance, India’s GCC ecosystem is poised for significant growth and influence in the coming decade.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.biospectrumindia.com/features/18/28385/indias-gccs-powering-the-global-life-sciences-value-chain.html
